z-logo
open-access-imgOpen Access
Viral resistance may limit the benefit of neuraminidase inhibitors therapy during an influenza pandemic
Author(s) -
Nathanaël Lapidus,
Magali Lemaître,
Fabrice Carrat
Publication year - 2007
Publication title -
hal (le centre pour la communication scientifique directe)
Language(s) - English
Resource type - Conference proceedings
Subject(s) - neuraminidase , pandemic , virology , neuraminidase inhibitor , pandemic influenza , limit (mathematics) , resistance (ecology) , covid-19 , medicine , biology , virus , disease , infectious disease (medical specialty) , mathematics , mathematical analysis , ecology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom